SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-23-110245
Filing Date
2023-10-20
Accepted
2023-10-19 21:01:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM tm2328826d9_posam.htm POS AM 21889
  Complete submission text file 0001104659-23-110245.txt   22963
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-260146 | Film No.: 231335847
SIC: 2834 Pharmaceutical Preparations